Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
147.50
-1.83 (-1.23%)
Jul 13, 2026, 12:00 PM EDT - Market open
Belite Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 352.93 | 31.68 | 88.16 | 42.09 | 17.34 |
Short-Term Investments | - | 139.49 | 113.47 | - | - | - |
Cash & Short-Term Investments | - | 492.42 | 145.15 | 88.16 | 42.09 | 17.34 |
Cash Growth | - | 239.25% | 64.65% | 109.45% | 142.67% | -32.30% |
Other Receivables | - | 0.7 | 0.58 | 0.84 | 0 | - |
Total Trade Receivables | - | 0.7 | 0.58 | 0.84 | 0 | - |
Other Current Assets | - | 1.15 | 1.35 | 0.95 | 0.72 | 0.09 |
Total Current Assets | 521.86 | 494.27 | 147.07 | 89.94 | 42.81 | 17.43 |
Net Property, Plant & Equipment | - | 0.78 | 0.97 | 1.3 | 1.35 | 0.09 |
Other Intangible Assets | - | 0.02 | 0.03 | - | - | - |
Long-Term Investments | 289.41 | 566.45 | 5.06 | - | - | - |
Other Long-Term Assets | - | 5.32 | 4.06 | 3.4 | 0.12 | 0.82 |
Total Assets | 811.27 | 780.56 | 152.13 | 94.64 | 44.27 | 18.35 |
Accrued Expenses | - | 9.64 | 5.76 | 3.33 | 1.91 | 1.56 |
Current Portion of Leases | - | 0.24 | 0.28 | 0.31 | 0.2 | - |
Other Current Liabilities | - | 0.01 | 0.01 | - | - | 0.07 |
Total Current Liabilities | - | 9.88 | 6.05 | 3.63 | 2.1 | 1.64 |
Long-Term Leases | - | 0.19 | 0.26 | 0.58 | 0.67 | - |
Total Long-Term Liabilities | - | 0.19 | 0.26 | 0.58 | 0.67 | - |
Total Liabilities | 15.48 | 10.07 | 6.31 | 4.21 | 2.77 | 1.64 |
Common Stock | - | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | - | 956.28 | 254.13 | 162.31 | 81.76 | 12.33 |
Accumulated Other Comprehensive Income | - | -0.54 | -0.66 | -0.37 | -0.39 | -0.2 |
Retained Earnings | - | -185.26 | -107.65 | -71.5 | -39.87 | -27.22 |
Total Common Shareholders' Equity | 795.79 | 770.49 | 145.82 | 90.43 | 41.5 | -15.09 |
Minority Interest | - | - | - | - | - | 31.81 |
Shareholders' Equity | 795.79 | 770.49 | 145.82 | 90.43 | 41.5 | 16.71 |
Total Liabilities & Equity | 811.27 | 780.56 | 152.13 | 94.64 | 44.27 | 18.35 |
Total Debt | - | 0.43 | 0.54 | 0.89 | 0.87 | 0 |
Net Cash (Debt) | - | 491.99 | 144.61 | 87.27 | 41.22 | 17.34 |
Net Cash Growth | - | 240.22% | 65.70% | 111.71% | 137.68% | -32.30% |
Net Cash Per Share | - | 14.67 | 4.74 | 3.28 | 2.06 | 1.81 |
Book Value | 795.79 | 770.49 | 145.82 | 90.43 | 41.5 | -15.09 |
Book Value Per Share | 22.43 | 22.97 | 4.78 | 3.40 | 2.08 | -1.58 |
Tangible Book Value | 795.79 | 770.47 | 145.79 | 90.43 | 41.5 | -15.09 |
Tangible Book Value Per Share | 22.43 | 22.97 | 4.77 | 3.40 | 2.08 | -1.58 |